[DOI] [PMC free article] [PubMed] [Google Scholar] Kang S
Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) that produced 24.2% average weight loss over 48 weeks in Phase 2 trials
Youll get both expert advice and the support of a community to help you feel motivated every step of the way
Some institutions now recommend withholding GLP-1RAs for 12 weeks before elective procedures, particularly if the patient is early in treatment or shows symptoms of gastroparesis
If you're considering GLP-1 treatment and have RA, it's essential to continue your RA medications, adopt healthy lifestyle habits, and work closely with your healthcare provider to ensure safe, effective use
In some cases, hypoglycemia can have serious consequences such as coma or even death